Modulation of lipoprotein metabolism by antisense technology: preclinical drug discovery methodology. (Q47864724)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation of lipoprotein metabolism by antisense technology: preclinical drug discovery methodology. |
scientific article published in January 2013 |
Statements
1 reference
Modulation of lipoprotein metabolism by antisense technology: preclinical drug discovery methodology. (English)
1 reference
Rosanne M Crooke
1 reference
Mark J Graham
1 reference
1 January 2013
1 reference
1 reference
1027
1 reference
309-324
1 reference
Identifiers
1 reference
1 reference